Cargando…

Predicting optimal response to B-cell depletion with rituximab in multiple sclerosis using CXCL13 index, magnetic resonance imaging and clinical measures

BACKGROUND: B-cell depleting drugs show promise for treating multiple sclerosis. OBJECTIVE: We sought predictors of optimal response to rituximab, a B-cell depleting antibody, to help guide therapy selection. METHODS: We performed a post hoc study of 30 relapsing multiple sclerosis patients with bre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alvarez, Enrique, Piccio, Laura, Mikesell, Robert J, Trinkaus, Kathryn, Parks, Becky J, Naismith, Robert T, Cross, Anne H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433328/ https://www.ncbi.nlm.nih.gov/pubmed/28607711 http://dx.doi.org/10.1177/2055217315623800

Ejemplares similares

Detection of cortical lesions in multiple sclerosis: A new imaging approach
por: Patel, Kevin R, et al.
Publicado: (2015)

Dimethyl fumarate-associated lymphopenia: Risk factors and clinical significance
por: Longbrake, Erin E, et al.
Publicado: (2015)

B-cell depletion with rituximab: a promising treatment for diffuse cutaneous systemic sclerosis
por: van Laar, Jacob M
Publicado: (2010)

Diffusion basis spectrum imaging provides insights into MS pathology
por: Sun, Peng, et al.
Publicado: (2019)

Intrathecally produced CXCL13: A predictive biomarker in multiple sclerosis
por: DiSano, Krista D, et al.
Publicado: (2020)

The association between handedness and clinicodemographic characteristics in people with multiple sclerosis: a brief report
por: Shirani, Afsaneh, et al.
Publicado: (2019)

Diffusion basis spectrum imaging for identifying pathologies in MS subtypes
por: Shirani, Afsaneh, et al.
Publicado: (2019)

Rituximab: B cell depletion: case report
Publicado: (2021)

Role of CXCL13 in the formation of the meningeal tertiary lymphoid organ in multiple sclerosis
por: Londoño, Ana C., et al.
Publicado: (2018)

Serum Levels of CXCL13 Are Associated With Teriflunomide Response in Patients With Multiple Sclerosis
por: Fissolo, Nicolás, et al.
Publicado: (2022)

Rituximab versus natalizumab, fingolimod, and dimethyl fumarate in multiple sclerosis treatment
por: Vollmer, Brandi L., et al.
Publicado: (2020)

Serious safety events in rituximab‐treated multiple sclerosis and related disorders
por: Vollmer, Brandi L., et al.
Publicado: (2020)

Association of circulating CXCL10 and CXCL11 with systemic sclerosis
por: Crescioli, Clara, et al.
Publicado: (2018)

The CXCL13 Index as a Predictive Biomarker for Activity in Clinically Isolated Syndrome
por: Pike, Steven C., et al.
Publicado: (2023)

CXCL13, CXCL10 and CXCL8 as Potential Biomarkers for the Diagnosis of Neurosyphilis Patients
por: Wang, Cuini, et al.
Publicado: (2016)

Repeated B-cell depletion with rituximab in rheumatoid arthritis
por: Edwards, J, et al.
Publicado: (2003)

B Cell Depletion: Rituximab in Glomerular Disease and Transplantation
por: Marinaki, S., et al.
Publicado: (2013)

Rituximab in early systemic sclerosis
por: Boonstra, Maaike, et al.
Publicado: (2017)

CXCL13/CXCR5 signalling is pivotal to preserve motor neurons in amyotrophic lateral sclerosis
por: Trolese, Maria Chiara, et al.
Publicado: (2020)

Is Rituximab-Associated Hypogammaglobulinemia Always Linked to B-Cell Depletion?
por: Damianaki, Anthie, et al.
Publicado: (2022)

BAFF Index and CXCL13 levels in the cerebrospinal fluid associate respectively with intrathecal IgG synthesis and cortical atrophy in multiple sclerosis at clinical onset
por: Puthenparampil, M., et al.
Publicado: (2017)

Alterations of host-gut microbiome interactions in multiple sclerosis
por: Cantoni, Claudia, et al.
Publicado: (2022)

Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis
por: Rabquer, Bradley J, et al.
Publicado: (2011)

An overview of pivotal trials and real-world evidence for CD20-depleting therapy in multiple sclerosis: Immunotherapy with rituximab, ocrelizumab, and ofatumumab
por: Ovchinnikov, Arkady, et al.
Publicado: (2022)

Novel CXCL13 transgenic mouse: inflammation drives pathogenic effect of CXCL13 in experimental myasthenia gravis
por: Weiss, Julia Miriam, et al.
Publicado: (2016)

Multiple sclerosis, rituximab, and COVID‐19
por: Langer‐Gould, Annette, et al.
Publicado: (2021)

Cxcl14 depletion accelerates skeletal myogenesis by promoting cell cycle withdrawal
por: Waldemer-Streyer, Rachel J, et al.
Publicado: (2017)

The recomBead Borrelia antibody index, CXCL13 and total IgM index for laboratory diagnosis of Lyme neuroborreliosis in children
por: Skogman, B. H., et al.
Publicado: (2017)

CSF CXCL13 and Chitinase 3-like-1 Levels Predict Disease Course in Relapsing Multiple Sclerosis
por: Lucchini, Matteo, et al.
Publicado: (2022)

TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis
por: Cignarella, Francesca, et al.
Publicado: (2020)

CXCL13 antibody for the treatment of autoimmune disorders
por: Klimatcheva, Ekaterina, et al.
Publicado: (2015)

Plasmacytoid Dendritic Cells Depletion and Elevation of IFN-γ Dependent Chemokines CXCL9 and CXCL10 in Children With Multisystem Inflammatory Syndrome
por: Caldarale, Francesca, et al.
Publicado: (2021)

Rituximab for the treatment of multiple sclerosis: a review
por: Chisari, Clara Grazia, et al.
Publicado: (2021)

B-Lymphocyte Depletion With Rituximab and β-Cell Function: Two-Year Results
por: Pescovitz, Mark D., et al.
Publicado: (2014)

Rapid depletion of B lymphocytes by ultra-low-dose rituximab delivered intrathecally
por: Svenningsson, Anders, et al.
Publicado: (2015)

Rituximab efficiently depletes B cells in lung tumors and normal lung tissue
por: Joly-Battaglini, Albane, et al.
Publicado: (2016)

Pathology of rituximab-induced Kaposi sarcoma flare: role of B-cell depletion
por: Pantanowitz, L, et al.
Publicado: (2009)

Prolonged Course of COVID-19-Associated Pneumonia in a B-Cell Depleted Patient After Rituximab
por: Kos, Igor, et al.
Publicado: (2020)

Acute Liver Failure Due to Echovirus 9 Associated With Persistent B-Cell Depletion From Rituximab
por: Bajema, Kristina L, et al.
Publicado: (2017)

Treatment of multiple sclerosis with rituximab: A Spanish multicenter experience
por: Gascón-Giménez, Francisco, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lc4smh54tihb04i20pt8vfsdv7